New Delhi, Pretr. The Central Government has allowed commercial export of Kovidshield and Covaccine keeping in mind that states and union territories and manufacturers have sufficient stock of anti-coronavirus vaccines. Official sources gave this information on Thursday.

However, the quantum of vaccines to be exported will be decided by the government every month to ensure that there is no shortfall in its availability in the country.

With the government allowing Serum Institute of India (SII) to export five million doses of Kovashield to Nepal, Tajikistan, Bangladesh and Mozambique, India recently resumed supplies of corona vaccines to the United Nations-backed ‘Covax’. The consignment of Kovishield vaccines will reach Nepal and Tajikistan this week.

An official source said that there are more than 22.72 crore left and unused doses available with the states and union territories. The production of vaccines is increasing due to which the stock will keep on increasing. He said that keeping this in mind the decision was taken to allow commercial export of Covishield and Covaccine.

The company has more than 24.89 crore doses of Covishield

Prakash Kumar Singh, director of government and regulatory affairs at SII, had recently apprised the Union health ministry that the Pune-based company has over 24.89 crore doses of Covishield and its stock is increasing day by day.

The government is expected to receive around 31 crore doses of Covishield and Covaccine from SII and Bharat Biotech in December. In the meantime, Zydus Cadila is expected to supply about 20 million doses of its three-dose Kovid vaccine, Xycovy-D.

Let us inform that the government has recently allowed the export of 20 million doses of the corona vaccine Covovax produced in India by the Serum Institute of India to Indonesia. According to official sources, the vaccine is not yet approved for emergency use in the country. The first consignment of Kovovax will reach Indonesia this week.

Edited By: Dhyanendra Singh Chauhan